94 related articles for article (PubMed ID: 7797937)
1. Phospholipase A2 is a circulating mediator in typhoid fever.
Keuter M; Dharmana E; Kullberg BJ; Schalkwijk C; Gasem MH; Seuren L; Djokomoeljanto R; Dolmans WM; van den Bosch H; van der Meer JW
J Infect Dis; 1995 Jul; 172(1):305-8. PubMed ID: 7797937
[TBL] [Abstract][Full Text] [Related]
2. Are events after endotoxemia related to circulating phospholipase A2?
Santos AA; Browning JL; Scheltinga MR; Lynch EA; Brown EF; Lawton P; Chambers E; Dougas I; Benjamin CD; Dinarello CA
Ann Surg; 1994 Feb; 219(2):183-92. PubMed ID: 8129489
[TBL] [Abstract][Full Text] [Related]
3. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
[TBL] [Abstract][Full Text] [Related]
4. Induction of circulating group II phospholipase A2 expression in adults with malaria.
Vadas P; Keystone J; Stefanski E; Scott K; Pruzanski W
Infect Immun; 1992 Sep; 60(9):3928-31. PubMed ID: 1500203
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
[TBL] [Abstract][Full Text] [Related]
6. Induction of circulating phospholipase A2 activity by intravenous infusion of endotoxin in patients with neoplasia.
Pruzanski W; Mackensen A; Engelhardt R; Stefanski E; Vadas P
J Immunother (1991); 1992 Nov; 12(4):242-6. PubMed ID: 1477075
[TBL] [Abstract][Full Text] [Related]
7. Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.
Guidet B; Piot O; Masliah J; Barakett V; Maury E; Bereziat G; Offenstadt G
Infection; 1996; 24(2):103-8. PubMed ID: 8740100
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns.
Nakae H; Endo S; Inada K; Yamashita H; Yamada Y; Takakuwa T; Kasai T; Ogawa M; Uchida K
Burns; 1995 Sep; 21(6):422-6. PubMed ID: 8554682
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
[TBL] [Abstract][Full Text] [Related]
11. Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis.
Hietaranta A; Kemppainen E; Puolakkainen P; Sainio V; Haapiainen R; Peuravuori H; Kivilaakso E; Nevalainen T
Pancreas; 1999 May; 18(4):385-91. PubMed ID: 10231844
[TBL] [Abstract][Full Text] [Related]
12. Plasma type II phospholipase A2 levels in patients with acute pancreatitis.
Miura M; Endo S; Kaku LL; Inoue Y; Sato N; Wakabayshi G; Baba E; Katsuya H; Inada K; Sato S
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):159-64. PubMed ID: 11758647
[TBL] [Abstract][Full Text] [Related]
13. Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy.
Rintala EM; Nevalainen TJ
Eur J Haematol; 1993 Jan; 50(1):11-6. PubMed ID: 8436209
[TBL] [Abstract][Full Text] [Related]
14. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis.
Green JA; Smith GM; Buchta R; Lee R; Ho KY; Rajkovic IA; Scott KF
Inflammation; 1991 Oct; 15(5):355-67. PubMed ID: 1757123
[TBL] [Abstract][Full Text] [Related]
15. Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.
Pruzanski W; Wilmore DW; Suffredini A; Martich GD; Hoffman AG; Browning JL; Stefanski E; Sternby B; Vadas P
Inflammation; 1992 Oct; 16(5):561-70. PubMed ID: 1428127
[TBL] [Abstract][Full Text] [Related]
16. Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever.
House D; Chinh NT; Hien TT; Parry CP; Ly NT; Diep TS; Wain J; Dunstan S; White NJ; Dougan G; Farrar JJ
J Infect Dis; 2002 Jul; 186(2):240-5. PubMed ID: 12134261
[TBL] [Abstract][Full Text] [Related]
17. A predictive model for the clearance of soluble phospholipase A2 during septic shock.
Vadas P; Pruzanski W; Farewell V
J Lab Clin Med; 1991 Nov; 118(5):471-5. PubMed ID: 1940588
[TBL] [Abstract][Full Text] [Related]
18. Increased serum phospholipase A2 activity in Malawian children with falciparum malaria.
Vadas P; Taylor TE; Chimsuku L; Goldring D; Stefanski E; Pruzanski W; Molyneux ME
Am J Trop Med Hyg; 1993 Oct; 49(4):455-9. PubMed ID: 8214274
[TBL] [Abstract][Full Text] [Related]
19. Blood cytokine and complement levels in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Kikuchi M; Baba N; Inada K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):291-300. PubMed ID: 7938903
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
